
Biotech Investment Could Be Approaching a ‘Golden Age’
J.P. Morgan strategist Jared Gross sketches out how small life sciences firms are now well-placed due to higher federal research funding and a more receptive FDA.
J.P. Morgan strategist Jared Gross sketches out how small life sciences firms are now well-placed due to higher federal research funding and a more receptive FDA.
The private equity giant has shifted from offices and malls to logistics, rentals and hospitality assets.
BlackRock forecasts a 1% economic contraction this year. The question: How will investors respond?
Report finds strong economic gains attributable to DB pension expenditures in 2020 despite COVID-19 outbreak.
They usually go up after the vote, with the uncertainty over. But maybe not this year, warns Schwab’s Liz Ann Sonders and some other Wall Street savants.
While company payouts hit a record, economic problems should slow that pace up ahead, a Janus Henderson study warns.
They are worried about the pandemic, GDP, inflation and Ukraine, he finds.
Despite the loss, the pension fund beat its benchmark by 53 basis points.
Market slump causes $262 billion drop in U.S. public pensions’ funding levels in June.
Lawsuit claims retail giant’s infrastructure investment was a ‘massive, self-imposed, undue drain’ on its finances.
Direct investments by sovereign wealth funds rise to record level in 2021.
It’s a classic recession portent. But inversion’s predictive record is spotty.